Recently, two approaches to down-regulate SOD1 expression in patients with SOD1-ALS [one utilizing an antisense oligonucleotide (Miller et al., 2020) and the other an adeno-associated viral vector (Mueller et al., 2020)] have been reported. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.